Standard BioTools Inc. Increase (Decrease) in Contract with Customer, Liability
Standard BioTools Inc. (LAB) reported Increase (Decrease) in Contract with Customer, Liability of -$30.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-05
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$460.00K.
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$29.93M.
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$114.00K.
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $700.00K.
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$1.31M.
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$4.14M, a 568.67% decline from fiscal 2023.
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $884.00K.
- Standard BioTools Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$3.47M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$460.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$30.39M 10-Q · filed 2026-08-05 | -$30.51M derived: sum of 3 quarters · filed 2026-08-05 | -$29.81M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$29.93M 10-Q · filed 2026-05-06 | -$30.05M derived: sum of 2 quarters · filed 2026-05-06 | -$29.35M derived: sum of 3 quarters · filed 2026-05-06 | -$30.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $586.00K derived: sum of 2 quarters · filed 2026-03-16 | -$787.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.31M 10-K · filed 2026-03-16 |
| 2025-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$673.00K derived: sum of 2 quarters · filed 2026-08-05 | -$1.20M 10-Q · filed 2025-11-04 | -$1.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.90M 10-Q · filed 2026-08-05 | -$2.47M derived: sum of 3 quarters · filed 2026-08-05 | -$4.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$527.00K 10-Q · filed 2026-05-06 | -$1.10M derived: sum of 2 quarters · filed 2026-05-06 | -$3.46M derived: sum of 3 quarters · filed 2026-05-06 | -$2.92M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$2.94M derived: sum of 2 quarters · filed 2026-03-16 | -$2.39M derived: sum of 3 quarters · filed 2026-03-16 | -$4.14M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.82M derived: sum of 2 quarters · filed 2025-11-04 | -$3.57M 10-Q · filed 2025-11-04 | -$2.91M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | -$1.21M 10-Q · filed 2025-08-15 | -$541.00K derived: sum of 3 quarters · filed 2026-03-16 | -$1.26M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | -$1.75M 10-Q · filed 2025-05-06 | -$1.08M derived: sum of 2 quarters · filed 2026-03-16 | -$1.80M derived: sum of 3 quarters · filed 2026-03-16 | -$1.67M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $666.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$53.00K derived: sum of 2 quarters · filed 2026-03-16 | $80.00K derived: sum of 3 quarters · filed 2026-03-16 | $884.00K 10-K · filed 2026-03-16 |
| 2023-09-30 | -$719.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$586.00K derived: sum of 2 quarters · filed 2024-11-06 | $218.00K 10-Q · filed 2024-11-06 | -$841.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $937.00K 10-Q · filed 2024-08-06 | -$122.00K derived: sum of 3 quarters · filed 2025-03-11 | -$973.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $804.00K 10-Q · filed 2024-05-09 | -$255.00K derived: sum of 2 quarters · filed 2025-03-11 | -$1.11M derived: sum of 3 quarters · filed 2025-03-11 | -$2.82M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$1.91M derived: sum of 2 quarters · filed 2025-03-11 | -$3.62M derived: sum of 3 quarters · filed 2025-03-11 | -$3.47M 10-K · filed 2025-03-11 |
| 2022-09-30 | -$851.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$2.56M derived: sum of 2 quarters · filed 2023-11-07 | -$2.41M 10-Q · filed 2023-11-07 | -$3.33M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.56M 10-Q · filed 2023-08-08 | -$2.48M derived: sum of 3 quarters · filed 2023-08-08 | -$4.15M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $155.00K 10-Q · filed 2023-05-09 | -$763.00K derived: sum of 2 quarters · filed 2023-05-09 | -$2.43M derived: sum of 3 quarters · filed 2023-05-09 | -$3.21M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$2.59M derived: sum of 2 quarters · filed 2023-03-14 | -$3.36M derived: sum of 3 quarters · filed 2023-03-14 | -$3.21M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.45M derived: sum of 2 quarters · filed 2022-11-09 | -$2.29M 10-Q · filed 2022-11-09 | -$1.44M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$775.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$619.00K 10-Q · filed 2022-08-09 | $234.00K derived: sum of 3 quarters · filed 2022-08-09 | -$473.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $156.00K 10-Q · filed 2022-05-09 | $1.01M derived: sum of 2 quarters · filed 2022-05-09 | $302.00K derived: sum of 3 quarters · filed 2022-05-09 | $1.23M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $853.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $146.00K derived: sum of 2 quarters · filed 2022-03-08 | $1.07M derived: sum of 3 quarters · filed 2022-03-08 | $2.11M 10-K · filed 2022-03-08 |
| 2020-09-30 | -$707.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $218.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.26M 10-Q · filed 2021-11-09 | $1.79M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $925.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.97M 10-Q · filed 2021-08-06 | $2.50M derived: sum of 3 quarters · filed 2022-03-08 | $3.62M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $1.04M 10-Q · filed 2021-05-07 | $1.58M derived: sum of 2 quarters · filed 2022-03-08 | $2.69M derived: sum of 3 quarters · filed 2022-03-08 | $2.52M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.65M derived: sum of 2 quarters · filed 2022-03-08 | $1.48M derived: sum of 3 quarters · filed 2022-03-08 | $2.13M 10-K · filed 2022-03-08 |
| 2019-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $942.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.59M 10-Q · filed 2020-11-09 | $2.11M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $476.00K 10-Q · filed 2020-08-07 | $997.00K derived: sum of 3 quarters · filed 2021-02-25 | $2.68M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $650.00K 10-Q · filed 2020-05-11 | $1.17M derived: sum of 2 quarters · filed 2021-02-25 | $2.86M derived: sum of 3 quarters · filed 2021-02-25 | $2.50M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $521.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.21M derived: sum of 2 quarters · filed 2021-02-25 | $1.85M derived: sum of 3 quarters · filed 2021-02-25 | $2.57M 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.33M derived: sum of 2 quarters · filed 2019-11-08 | $2.05M 10-Q · filed 2019-11-08 | $2.78M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $368.00K 10-Q · filed 2019-08-07 | $1.10M derived: sum of 3 quarters · filed 2020-02-27 | |
| 2018-03-31 | $720.00K 10-Q · filed 2019-05-07 | $1.45M derived: sum of 2 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $728.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.64M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $908.00K 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | -$274.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |